CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.
Citation:
CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.
CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.
Citation:
CAI Hong-wei, LI Yan-hong, ZHANG Zi-bao, DENG Ya-zhong. The significance, development and prospects of healthcare data integration in new drug clinical trialsJ. Acta Pharmaceutica Sinica, 2015,50(11): 1415-1419.
The significance, development and prospects of healthcare data integration in new drug clinical trials
With the deployment of electronic medical records systems, more and more routine clinical data are recorded electronically, which become a potential data source for new drug clinical trials. In this paper, we summarized the opportunities, challenges, obstacles and the latest development in this field.